X0206 3 2015-02-13 0 0001590714 Platform Specialty Products Corp PAH 0001521239 Permira IV Managers LP C/O PERMIRA IV MANAGERS L.P. TRAFALGAR COURT LES BANQUES Y7 GY1 3QL GUERNSEY 0 0 1 0 0001638696 Nalozo Cayman GP Ltd. C/O PERMIRA LUXEMBOURG S.A R.L. 282 ROUTE DE LONGWY LUXEMBOURG N4 L-1940 LUXEMBOURG 0 0 1 0 0001638571 Nalozo L.P. C/O PERMIRA LUXEMBOURG S.A R.L. 282 ROUTE DE LONGWY LUXEMBOURG N4 L-1940 LUXEMBOURG 0 0 1 0 Series B Preferred Stock, par value $0.01 per share 27.14 Common Stock 22107590 I See Footnote Each share of Series B convertible preferred stock entitles the holder on exercise to buy one share of Common Stock for $27.14, provided, that 19,296,242 shares may not be converted until the earlier of the expiration or early termination of any waiting period under the Hart Scot Rodino Antitrust Improvements Act of 1976, as amended. This report is filed jointly by Permira IV Managers L.P. ("Permira IV"), Nalozo L.P. ("Nalozo LP") and Nalozo Cayman GP Ltd. ("Nalozo GP") (together, the "Reporting Persons"). Nalozo GP is the general partner of Nalozo LP, and Nalozo LP is the direct beneficial owner of 22,107,590 shares of Series B convertible preferred stock of the Company. Each of the other Reporting Persons may be deemed an indirect beneficial owner of shares of Series B convertible preferred stock held by Nalozo LP, provided, however, that each of them disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Persons' pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 or for any other purpose. /s/ Kees Jager, as Authorized Signatory for Permira IV Managers L.P. 2015-04-06 /s/ John Coyle, as Authorized Signatory for Nalozo Cayman GP Ltd. 2015-04-06 /s/ John Coyle, as Authorized Signatory for Nalozo L.P. 2015-04-06